These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 4367343

  • 1. Cell-mediated and humoral immunity studies of murine and hamster sarcoma virus-induced producer and non-producer tumors in syngeneic animals.
    McCoy JL, Ting RC, McCoy NT, Reisher JI, Chan SP, Law LW.
    Int J Cancer; 1974 May 15; 13(5):731-41. PubMed ID: 4367343
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Histocompatibility-linked genetic control of specific immune responses to viral infection.
    McDevitt HO, Oldstone BA, Pincus T.
    Transplant Rev; 1974 May 15; 19(0):209-25. PubMed ID: 4135405
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J.
    Ser Haematol; 1972 May 15; 5(4):93-122. PubMed ID: 4133765
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. H-2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes.
    Gomard E, Duprez V, Henin Y, Levy JP.
    Nature; 1976 Apr 22; 260(5553):707-9. PubMed ID: 177884
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB, Aoki T, Nunn M, Lavrin DH, Soares N, Gazdar A, Holden H, Chang KS.
    J Natl Cancer Inst; 1974 Oct 22; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey).
    McCoy JL, Ting RC, Morton DL, Law LW.
    J Natl Cancer Inst; 1972 Feb 22; 48(2):383-91. PubMed ID: 4347035
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immune cytolysis of murine tumor cells mediated by xenogeneic "immune" RNA.
    Kern DH, Pilch YH.
    Int J Cancer; 1974 May 15; 13(5):679-88. PubMed ID: 4843880
    [No Abstract] [Full Text] [Related]

  • 14. Immune responses to virus induced experimental leukemia and to human leukemia.
    Herberman RB.
    Johns Hopkins Med J Suppl; 1974 May 15; 3():3-14. PubMed ID: 4371287
    [No Abstract] [Full Text] [Related]

  • 15. Cell-surface and virion-envelope antigens shared by radiation leukemia virus (RadLV) and other murine c-type viruses.
    Ferrer JF.
    Int J Cancer; 1973 Sep 15; 12(2):378-88. PubMed ID: 4134124
    [No Abstract] [Full Text] [Related]

  • 16. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
    Cohen AM, Millar RC, Ketcham AS.
    Cancer Res; 1972 Nov 15; 32(11):2421-6. PubMed ID: 5082590
    [No Abstract] [Full Text] [Related]

  • 17. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
    Levy JP, Leclerc JC.
    Adv Cancer Res; 1977 Nov 15; 24():1-66. PubMed ID: 66859
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Mouse rosette forming cells in transplantation immunity].
    Brondz BD, Eliseeva LS, Kotomina IF, Egorova SG.
    Tsitologiia; 1974 Jan 15; 16(1):74-81. PubMed ID: 4142816
    [No Abstract] [Full Text] [Related]

  • 20. The specificity of effector T cells activated by tumours induced by murine oncornaviruses.
    Shellam GR, Knight RA, Mitchison NA, Gorczynski RM, Maoz A.
    Transplant Rev; 1976 Jan 15; 29():249-76. PubMed ID: 58459
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.